A pilot study to determine whether health care professionals perceive stigma in heterozygote carrier identification and disclosure decisions

American Journal of Medical Genetics, Part A

Volumn 155, Issue 8, 2011, Pages 1897-1905

  Moffett, Alexander ^a   Ross, Lainie Friedman ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Cystic fibrosis; Disclosure; Disparities; Duchenne muscular dystrophy; Hemoglobinopathy; Heterozygote carrier; Race ethnicity; Stigma

Indexed keywords

ADULT; ARTICLE; ATTITUDE; CONTROLLED STUDY; CYSTIC FIBROSIS; DUCHENNE MUSCULAR DYSTROPHY; FEMALE; GENETIC ANALYSIS; HEALTH CARE PERSONNEL; HEALTH ORIENTATION SCALE; HEMOGLOBINOPATHY; HETEROZYGOTE; HIV STIGMA SCALE; HUMAN; MALE; PARENT; PILOT STUDY; PRIORITY JOURNAL; RATING SCALE; SELF DISCLOSURE; SELF ESTEEM; SEX DIFFERENCE; SOCIAL STIGMA; X CHROMOSOME LINKED DISORDER;

CYSTIC FIBROSIS; DISCRIMINATION (PSYCHOLOGY); ETHNIC GROUPS; FEMALE; HEALTH PERSONNEL; HEMOGLOBINOPATHIES; HETEROZYGOTE; HUMANS; KNOWLEDGE OF RESULTS (PSYCHOLOGY); MALE; MUSCULAR DYSTROPHY, DUCHENNE; PILOT PROJECTS; SELF DISCLOSURE; SHAME;

EID: 79960559473     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.34091     Document Type: Article

References (53)

1. American College of Obstetricians and Gynecologists. 2005a. Update on carrier screening for cystic fibrosis. ACOG Committee Opinion No. 325. Obstet Gynecol 106:1465-1468.
2. American College of Obstetricians and Gynecologists Committee. 2005b. Hemoglobinopathies in pregnancy. Obstet Gynecol 106:203-210.
3. Acharya K, Ackerman PD, Ross LF. 2005. Pediatricians' attitudes toward expanding newborn screening. Pediatrics 116:476-484.
4. Apel SB. 2001. Privacy in genetic testing: Why women are different. South Calif Interdiscip Law J 11:1-26.
5. Bamshad M, Wooding S, Salisbury BA, Stephen JC. 2004. Deconstructing the relationship between genetics and race. Nat Rev Genet 5:598-609.
6. Benjamin C. 2001. Aspects of stigma associated with genetic conditions. In: Mason T, Carlisle C, Watkins C, Whitehead E, editors. Stigma and social exclusion in health care. London: Routledge.
7. Berger BE, Ferrans CE, Lashley FR. 2001. Measuring stigma in people with HIV: Psychometric assessment of the HIV stigma scale. Res Nurs Health 24:518-529.
8. Bradley DM, Parsons EP, Clark AJ. 1993. Experience with screening newborns for Duchenne muscular dystrophy in Wales. Br Med J 306:357-360.
9. Braun L. 2002. Race, ethnicity, and health: Can genetics explain disparities? Perspect Biol Med 45:159-174.
10. Bunn JY, Solomon SE, Miller C, Forehand R. 2007. Measurement of stigma in people with HIV: A reexamination of the HIV Stigma Scale. AIDS Educ Prev 19:198-208.
11. Chattopadhyay S. 2006. 'Rakter dosh' - corrupting blood: The challenges of preventing thalassemia in Bengal, India. Soc Sci Med 63:2661-2673.
12. Collins FS. 2004. What we do and don't know about 'race', 'ethnicity', genetics and health at the dawn of the genome era. Nat Genet 36:S13-S15.
13. Cowan RS. 2008. Heredity and hope: The case for genetic screening. Cambridge: Harvard University Press.
14. d'Agincourt-Canning L. 2001. Experiences of genetic risk: Disclosure and the gendering of responsibility. Bioethics 15:231-247.
15. Denayer L, Welkenhuysen M, Evers-Kiebooms G, Cassiman JJ, Van den Berghe H. 1996. The CF carrier status is not associated with a diminished self-concept or increased anxiety: Results of psychometric testing after at least 1 year. Clin Genet 49:232-236.
16. Drousiotou A, Ioannou P, Georgiou T, Mavrikiou E, Christopoulos G, Kyriakides T, Voyasianos M, Argyriou A, Middleton L. 1998. Neonatal screening for Duchenne muscular dystrophy: A novel semiquantitative application of the bioluminescence test for creatine kinase in a pilot national program in Cyprus. Genet Test 2:55-60.
17. Dyson S. 2005. Ethnicity and screening for sickle cell/thalassaemia. Edinburgh: Elsevier.
18. Emery AEH. 1993. Duchenne muscular dystrophy, 2nd edition. Oxford: Oxford University Press.
19. Evers-Kiebooms G, Denayer L, Welkenhuyzen M, Cassiman JJ, Van den Berghe H. 1994. A stigmatizing effect of the carrier status for cystic fibrosis? Clin Genet 46:336-343.
20. Gordon C, Walpole I, Zubrick SR, Bower C. 2003. Population screening for cystic fibrosis: Knowledge and emotional consequences 18 months later. Am J Med Genet Part A 120A:199-208.
21. Jenerette C, Funk M, Murdaugh C. 2005. Sickle cell disease: A stigmatizing condition that may lead to depression. Issues Ment Health Nurs 26:1081-1101.
22. Johnson RL, Roter D, Powe NR, Cooper LA. 2004. Patient race/ethnicity and quality of patient-physician communication during medical visits. Am J Public Health 94:2084-2090.
23. Kark JA, Posey DM, Schumacher HR, Ruehle CJ. 1987. Sickle-cell trait as a risk factor for sudden death in physical training. New Engl J Med 317:781-787.
24. Karetti M, Karetti M, Yardumian A, Karetti D, Modell B. 2004. Informing carriers of beta-thalassemia: Giving the good news. Genet Test 8:109-113.
25. Kellerman SE, Herold J. 2001. Physician response to surveys. A review of the literature. Am J Prevent Med 20:61-67.
26. Kenen RH, Schmidt RM. 1978. Stigmatization of carrier status: Social implications of heterozygote screening programs. Am J Public Health 68:1116-1120.
27. King M, Dinos S, Shaw J, Watson R, Stevens S, Passetti F, Weich S, Serfaty M. 2007. The stigma scale: Development of a standardised measure of the stigma of mental illness. Br J Psychiatry 190:248-254.
28. Lewontin R, Rose S, Kamin LJ. 1984. Not in our genes: Biology, ideology, and human nature. New York: Pantheon Books.
29. Linn LS, Yager J, Leake B. 1990. Professional vs. personal factors related to physicians' attitudes toward drug testing. J Drug Educ 20:95-109.
30. MacDonald DJ, Sarna L, van Servellen G, Bastani R, Giger JN, Weitzel JN. 2007. Selection of family members for communication of cancer risk and barriers to this communication before and after genetic cancer assessment. Genet Med 9:275-282.
31. Michlitsch J, Azimi M, Hoppe C, Walters MC, Lubin B, Lorey F, Vichinsky E. 2009. Newborn screening for hemoglobinopathies in California. Pediatr Blood Cancer 52:486-490.
32. Miller FA, Robert JS, Hayeems RZ. 2009. Questioning the consensus: Managing carrier status results generated by newborn screening. Am J Pub Health 99:210-215.
33. Mitchell BL. 2007. Sickle cell trait and sudden death-bringing it home. J Natl Med Assoc 99:300-305.
34. National Newborn Screening Status Report. 2010. Available at Accessed December 13, 2010.
35. Parsons EP, Clarke AJ, Bradley DM. 2003. Implications of carrier identification in newborn screening for cystic fibrosis. Arch Dis Child Fetal Neonatal Ed 88:F467-F471.
36. R Development Core Team. 2008. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing.
37. Rund D, Rachmilewitz E. 2005. β-Thalassemia. N Engl J Med 353:1135-1146.
38. Sabin JA, Rivara FP, Greenwald AG. 2008. Physician implicit attitudes and stereotypes about race and quality of medical care. Med Care 46:678-684.
39. Sabin JA, Nosek BA, Greenwald AG, Rivara FP. 2009. Physicians' implicit and explicit attitudes about race by MD race, ethnicity, and gender. J Health Care Poor Underserved 20:896-913.
40. Schulman KA, Berlin JA, Harless W, Kerner JF, Sistrunk S, Gersh BJ, Dubé R, Taleghani CK, Burke JE, Williams S, Eisenberg JM, Escarce JJ. 1999. The effect of race and sex on physicians' recommendations for cardiac catheterization. N Engl J Med 340:618-626.
41. Serjeant GR, Serjeant BE. 2001. BT Sickle cell diseases. Oxford: Oxford University Press.
42. Smedley BD, Stith AY, Nelson AR, editors. 2002. Unequal treatment: Confronting racial and ethnic disparities in health care. Washington DC: National Academy Press.
43. Taylor S. 2005. Gender differences in attitudes among those at risk for Huntington's disease. Genet Test 9:152-157.
44. Tishkoff SA, Kidd KK. 2004. Implications of biogeography of human populations for 'race' and medicine. Nat Genet 36:S21-S27.
45. Treadwell MJ, McClough L, Vichinsky E. 2006. Using qualitative and quantitative strategies to evaluate knowledge and perceptions about sickle cell disease and sickle cell trait. J Natl Med Assoc 98:704-710.
46. van Brakel WH. 2006. Measuring health-related stigma: A literature review. Psychol Health Med 11:307-334.
47. van Ryn M, Fu SS. 2003. Paved with good intentions: Do public health and human service providers contribute to racial/ethnic disparities in health? Am J Public Health 93:248-255.
48. Wailoo K. 2001. Dying in the city of the blues: Sickle cell anemia and the politics of race and health. Chapel Hill: University of North Carolina Press.
49. Wailoo K, Pemberton S. 2006. The troubled dream of genetic medicine. Baltimore: Johns Hopkins University Press.
50. Williams B, Mukhopadhyay S, Dowell J, Coyle J. 2007. Problems and solutions: Accounts by parents and children of adhering to chest physiotherapy for cystic fibrosis. Disabil Rehabil 29:1097-1105.
51. Wooldridge EQ, Murray RF. 1984. The psychodynamics associated with sickle cell gene carrier status. Birth Defects Orig Artic Ser 20:169-186.
52. Wooldridge EQ, Murray RF. 1988. The health orientation scale: A measure of feelings about sickle cell trait. Soc Biol 35:123-136.
53. Yaeger R, Avila-Bront A, Abdul K, Nolan PC, Grann VR, Birchette MG, Choudhry S, Burchard EG, Beckman KB, Gorroochurn P, Ziv E, Consedine NS, Joe AK. 2008. Comparing genetic ancestry and self-described race in African Americans born in the United States and Africa. Cancer Epidemiol Biomarkers Prev 17:1329-1338.